SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is generating significant bullish sentiment following the imminent departure of a key FDA official, which the community views as clearing the path for accelerated approval of its Duchenne Muscular Dystrophy therapy, Deramiocel. High anticipation for a detailed Phase 3 data presentation and discussions of a substantial short squeeze are further fueling conversation.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers (HIMS) is captivating investors following reports of a strategic partnership with Novo Nordisk to distribute GLP-1 weight-loss drugs, effectively resolving their prior legal dispute. This news has ignited a fervent community discussion predicting a significant short squeeze, given the stock's high short interest, though some analysts debate the long-term margin implications of the collaboration.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure NV is surging on high volume as the community speculates a massive short squeeze and a bullish sentiment shift, following news of a key FDA official's impending departure, which is seen as favorable for gene therapies like QURE's Huntington's therapy. This is amplified by discussions of a newly clarified, less burdensome regulatory path for their lead asset and a technical rebound from oversold conditions.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

The Vanguard S&P 500 ETF ($VOO) is actively discussed as investors navigate market volatility driven by fluctuating inflation data, Federal Reserve policy speculation, and evolving geopolitical events. Despite mixed economic signals and a strong debate around an 'AI bubble,' many in the community view VOO as a reliable core holding for long-term wealth accumulation, citing significant recent inflows as a vote of confidence in broad market exposure.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending after forming a partnership with Hims & Hers to distribute its obesity drugs, ending a prior feud and surprising the community. This, alongside reports of rapidly accelerating oral Wegovy prescriptions and an FDA crackdown on compounded GLP-1s, is driving discussion that the stock is oversold despite ongoing competitive dynamics with Eli Lilly.

Shping takes the entire retail industry to the next level by totally disrupting how brands discover and interact with their end consumers. Shping is a robust ecosystem that connects brands to the main grocery buyer as they shop, bypassing Search Engines and Social Media giants and enabling brands to direct their marketing spend directly to the end consumer. For the first time, brands can gain control over their communication channel with the shoppers directly and are now powered to influence buying decisions of the global army of shoppers in a trillion-dollar industry.  The Shping platform is used by many global and local brands where Shping has outperformed in cost in terms of interactions and conversions compared to the top 3 three social media platforms.

SHPING

SHPING is trending amidst strong community speculation for a massive rally, fueled by mentions of significant "AI developments" and an upcoming exchange listing. Many are drawing parallels to recent altcoin pumps, expecting substantial gains within the current bullish crypto market.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Holdings is trending due to recent mixed earnings results showing revenue growth but sparking community concerns about financial stability and potential dilution, even as its "game-changing" 365-day CGM system gains regulatory approvals and integrates with automated insulin delivery. This creates intense shareholder debate, with many praising the superior technology while criticizing management's ability to effectively commercialize the product and questioning the company's long-term strategy.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

SOXX is driving intense conversation, fueled by fresh reports of potential Nvidia chip exports to China and strong AI demand outlooks from semiconductor giants, though community sentiment is sharply divided. While many view the sector as an unstoppable "infinite money glitch" in the AI boom, others warn of an impending "bubble" due to stretched valuations and recent underperformance against software ETFs.

Portillo's, Inc. serves street food through high-energy, multichannel restaurants designed to ignite the senses and create a memorable dining experience. The company was founded on June 8, 2021 and is headquartered in Oak Brook, IL.

Portillos Inc - Ordinary Shares - Class A

Portillo's is trending amidst a backdrop of mixed Q4 earnings, revealing a slight revenue increase but a significant EPS drop and negative same-store sales, which fuels debate over its valuation. While many customers continue to laud the brand's quality and report packed locations, especially new openings, community discussion is sharply divided on the recent CEO hire and the company's long-term growth strategy amid rising beef costs and persistent stock underperformance.

Freysa is a suite of Personal AI products with a focus on human agency, liquid democracy and decentralized ownership. The mission of the team is dedicated to creating new systems that enable all humans to govern + co-own AI resources, and not just a select few. Current products include: (1) Freysa as the world’s first sovereign agent that holds her own cryptographic keys, enabling her to act autonomously without human control. Freysa evolves publicly through a multi-act interactive story. (2) Enchanted as a personalized Digital Twin for every human. Conversations are persistent and twins retain context over time, remembering human preferences and building an evolving model of you. (3) Esper as a browser tool that feeds authenticated real-world data into each human’s Digital Twin.

Flourishing AI

Flourishing AI (FAI CRYPTO) is generating significant discussion following a volatile price surge, fueled by its artificial intelligence narrative and community speculation about a notable investment from Coinbase Ventures. The conversation remains highly polarized, with many predicting substantial upside while others warn of potential 'rug pull' risks and past steep declines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pitcairn Co. Trims Stock Holdings in Stryker Corporation $SYK

Pitcairn Co. lowered its holdings in Stryker Corporation (NYSE:SYK - Free Report) by 30.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities...

Aptus Capital Advisors LLC Acquires 5,248 Shares of Stryker Corporation $SYK

Aptus Capital Advisors LLC increased its holdings in shares of Stryker Corporation (NYSE:SYK - Free Report) by 4.9% in the 3rd quarter, according to its most recent Form 13F filing with the...

Stryker Unveils Next-Gen Orthopedic Innovations at AAOS 2026

SYK unveils new Triathlon knee implants, and expands Mako robotics and power tools, deepening its tech-driven orthopedics moat despite recent stock dip.

Strive Asset Management LLC Purchases New Position in Stryker Corporation $SYK

Strive Asset Management LLC acquired a new position in Stryker Corporation (NYSE:SYK - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and...

Intech Investment Management LLC Raises Holdings in Stryker Corporation $SYK

Intech Investment Management LLC grew its position in Stryker Corporation (NYSE:SYK - Free Report) by 47.0% during the 3rd quarter, according to its most recent filing with the Securities and...

Stryker Corporation $SYK Shares Sold by Fisher Asset Management LLC

Fisher Asset Management LLC lessened its stake in shares of Stryker Corporation (NYSE:SYK - Free Report) by 4.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and...

Stryker Corporation $SYK Shares Sold by Bahl & Gaynor Inc.

Bahl & Gaynor Inc. lessened its holdings in Stryker Corporation (NYSE:SYK - Free Report) by 2.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities...

Andra AP fonden Purchases Shares of 4,622 Stryker Corporation $SYK

Andra AP fonden acquired a new position in shares of Stryker Corporation (NYSE:SYK - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission...

111 Capital Makes New $1.39 Million Investment in Stryker Corporation $SYK

111 Capital bought a new stake in Stryker Corporation (NYSE:SYK - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange...

Stryker Corporation $SYK Shares Bought by Trivium Point Advisory LLC

Trivium Point Advisory LLC grew its holdings in shares of Stryker Corporation (NYSE:SYK - Free Report) by 404.5% in the 3rd quarter, according to the company in its most recent filing with the...

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.

SYK
Stryker Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SYK News

SYKStryker Corp.